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In patients with acute myocardial infarction with either suc- 
cessfz! thrombolytic therapy or percutaneous transluminai 
coro~ry angioplasty, the response of the postischemic myo- 
cnrdium to dobutamine is influenced by at least five factors, 
two of which (extent of viable tissue and degree of residual 
stenosis) are depicted in Figure 1. For the sake of simplicity, 
the size of the risk area, the spatial extent and magnitude of 
collateral blood flow and the effect of beta-blockade are not 
depicted. If the size of the risk area is small (~12% of the 
endocaniial circumference), function within that area is deter- 
mined by that of the adjacent myocardium through the teth- 
ering effect (1). The amount of collateral blood flow and extent 
of beta-blockade also modulate the response by causing less 
myocardial dysfunction for any given dose of dobutamine (23). 
In the absence of a residual stenosis, the transmura1 extent 
of viable tissue within the postischemic myoeardium deter- 
mines the degree of wall thickening for any given dose of 
do&amine (Fig. 1, panel A) (4). Low dose dobutamine 
increases wall thickening only if necrosis is minimal or absent. 
In the presence of necrosis involving more of the myocardial 
thickness, systolic thickening starts increasing only at moderate 
doses of dobutamine, with further incmases seen at high doses. 
If the necrosis is transmural, wall thickening does not incmase 
at any dose. Thu$ m the absence of a stenosis, no response at 
any dose of dobutamine identities nonviable myocxdium. 
In add&m to the extent of necrosis, the degree of residual 
stenosis also inguences the response of the postischemic 
myo@rdium to dobutamine (Fig. 1, panel B) (5). To achieve 
improvement in wail thickening, myocardial oxygen delivery 
must increase in proportion to oxygen demand, which, at any 
given dose of dobmamine, is infhtenced by the amount of 
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viable tissue. In the absence of a stenosis, blood flow increases 
in proportion to oxygen demand (6). If a stenosis limits the 
required increase in blood flow and oxygen delivery, &hernia 
occurs and wall thickening diminishes despite the presence of 
viable myocardium. Induction of ischemia in dysfunctional 
myocardium, therefore, suggests the presence of both viable 
myocardium and a physiologically significant stenosis. 
A perfusion/metabolism mismatch on positron emission 
tomography implies the presence of rest ischemia (7,8). It is 
therefore not surprising that it predicts recovery of regional 
function after revascuiarization. Because it represents induc- 
ible ischemia, a “biphasic response” within a dysfunctional 
segment on dobutamine c&cardiography also predicts recov- 
ery in function after ievmularization (9). If the necrosis is 
minimal (Fig. 1 [2 in panel A]) and the stenosis severe (Fig. 1 
[d in panel B]), ischemia occurs at a low dose of dobutamine. 
For the same amount of necrosis, however, &hernia in the 
presence of a moderate stenosis (Fig. 1 [c in panel BJ) occurs 
only at a higher dose of dobutamine and could be missed if 
infusion of the drug is terminated at a lower dose. Every 
attempt should be made to demonstrate the presence of 
&hernia in a dysfunctional myocardial segment because it may 
be the best predictor of recovery of function after revascular- 
ization. 
The lack of demonstration of ischemia, however, does not 
rule out the presence of viability in the postischemic myocar- 
dium. For instance, if the extent of necrosis or the degree of 
stenosis, or both, is only miniial or absent, then function 
within the postischemic myocardium will improve incremen- 
tally at higher doses of dobutamine. Because blood flow 
limitation is not the primary cause of the dysfunction at rest, 
revascularization of such myocardium is unnecesary. Indeed, 
rest function in this bed wih most likely improve spontaneously 
over several days to weeks and become hypokinetic or normal- 
ize (1411). Because most left ventricular wall thickening at 
rest occurs because of endocardial thickening, (12,13) a mild 
reduction in thickening (hypokinesia) indicates that most of 
the myocardium has escaped necrosis and is hence viable (14). 
Consequently, in the absence of reduced rest flow, hypokinetic 
segments Deed not be evaluated for the presence of iability. 
Unlike acute myccardial infarction, the pathophysiology of 
left ventricular dysfunction in patients with chronic coronary 
artery disease is poorly understood, mostly due to the paucity 
of experimental data. One predominant concept is that the 
decrease in rest function is the result of a stenosis-induced 
reduction in rest blood flow (15). However, if chronic ischemia 
were the only cause of this phenomenon, dobutamine infusion 
would result in further dysfimction. Several studies (16~19), 
including the one by Ghan et al. (19) in this issue of the Journal 
have demonstrated that improvement in function can be seen 
in these patients in the presence of dobutamine. These data 
imply that the amount of flow reserve in the dystimctionaI 
segmentsinthesepatkntsexceedsthedefpofftm&& 
impairment. It is therefore likely that myoc&ial hmction is 
l-Immegulated compared with rest blood tlow (20+21) and may 
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explain why low dose dobutamine improves function in these 
segments. In this instance, because flow limitation is the cause 
of reduced myocardial function, revascularization should result 
in its improvement. 
Another emerging concept to explain myocardial dysfunc- 
tion in chronic coronary artery disease is that of “repetitive 
stunning” (22). Rest blood flow may he normal in patients with 
chronic left ventricular dysfunction in regions supplied hy 
either occluded vessels (because of collateral flow) (2223) or 
severely stenotic vessels (hecause of adequate anterograde and 
collateral Ilow) (24). These patients however, have minimal 
flow reserve, which limits oxygen detiiety even during modest 
physical effort. The resulting oxygen supply/demand mismatch 
causes ischemia, repetitive episc&s of which result in perpet- 
ual my-dial “stunning.” In such patients, function improves 
at low doses of dohutamine because of some residual coronary 
flow reserve, before becoming worse at hiir doses (the 
biphasic response) (9). Revascularization in this setting also 
results in recovery of function. 
One way to unify these two concepts of myocardial dysfunc- 
tion in chronic coronary artery disease is,to take into account 
the natud history of the dkease. When the stenosis is 
suhcriti@ rest flow is normal. but repetitive stunning can 
result in persistent myocardial dysfunction. In this instance, 
positron emisii tomogra~ will show nomd rest perfusion 
(23,24). As the Stencsk severity worsens, rest ffow till he 
reduc& and hoth metabolii and function will he downregu- 
iatedasaco~.Inthk&tance,positronemksion 
t~wiushowreduoedperfiawowithintactme~ 
iism(7#.Whenb4oodBowisredueedbefowlevekcapabkof 
Fii 1. Eipected response to different doses of d&utamim after 
reflow has been achieved in pa&x% with acute myrrardial infarction 
and abnormal function within the infarct WW. M A depicts the 
extent of necro& 1 = none: 2 = minimal; 3 = moderate: 4 = 
extensive. Pad B illustrates the severity of stenosis whereby the 
&~ofste~i;&fmedioremaditsabilitytar~corMlary 
tlow ressm: a = normal Rap resepe: b = rm&tiy reduced Eow reserve; 
c = moderately reduced tIow reserve: d = severely reduced RGV 
reserve: e = reduced rest tlow. Pad C denotes the pm&k uxnbi- 
aatioa of the extent of necrosir @nad A) and degree of st& (paaet 
B).E’a&Dsbwnthees~Wearesponsetod&tami~aa~xdiogto 
theStXWiOshowniIlprlC.AITWSintheSdllledirecticnmficate 
agreaterresponvthanthatatthepnGousstage.Tlierespomcsin 
chroGcaxonaryaneryd&asecouidbedi&rentfromthosedepkred 
here.depen&gontheextentofJnyoWMdl3WWg&~and 
coUateralperfusioa.SeetextforQtaik--nochange. 
maintaining celhdar viability: necrOIiS and fibrosis will occur. 
In this situation, positron emission tomography will demon- 
strate lack d both Bou and metabolii. The mechanism or 
mechanisms responsible for dy5function in a particular patien5 
or even in different myocardial segments within the same 
patient, are di5cuit to ascertain without an assessment of 
myocxdial blood fIow. 
Onthebgsisofthepreviousdisnmion,onecanseesomeof 
the&fieienciesinthestlrdybyChanelaL(19).~~harenot 
Avery different from those found in other similar studies. Why 
wasdoMaminestoppedatadose0f10lrgr~perminin.50% 
of patients and not in the other .50%? What were the results in 
patients who continued to receive incremental doses of do&t- 
amine?whydidtbealIthors,!ikeotbelsbefmtbemdefine 
ouIyimprov~~thlinduringduriryas- 
1610 KAUL 
EDITORIAL COMMENT 
for viability? What would their results have looked like if they 
had also included worsening of function? Admittedly. akinetic 
segments can show worsening of function simply by changes in 
load, but it is unlikely that all such segments within a,vascular 
bed will behave similarly. For example, akinettc apical seg 
menh are more likely to show dyskinesia with change in load 
than akinetic regments elsewhere in the left ventricle. Because 
revascularization is not provided to individual myocardial 
segments but to an entire vascular territory. it is crucial to 
evaluate the aggregate behavior of an entire territory rather 
than just a single segment before proceeding with a revascu- 
rarization procedure. In the study by Chan et al. (19). the 
finding that 50% of hypokinetic segments did not show im- 
proved function during dobutamine infusion implies that ei- 
ther these segments were supplied by severely stcnotic vessels 
(Fig l [‘i in panel A and d in panel B]) or the dose of 
dobutamme required to elicit contractile reserve was not 
achieved. Obviisly, therefore. dobutamine echocardiography 
did not fare as well as positron emission tomography for 
assessing viability in these segments. 
Why were cutoffs used for fluorine-lg fluorodeoxyglucose 
uptake to define viability? If we ignore the partial volume 
effect, then the myocardial uptake of this tracer should be 
roughly proportional to the number of viable cells. Viability 
within a myocardial segment is a continuum based on the 
number of nonnecrmd cells rather than an “all or none” 
phenomenon (25.26). Was Row by positron emission tomogra- 
phy normal in some dysfunctional segments? How did these 
segments respond to dobutamine? It is also important to point 
out that viability data on positron emission tomography are 
usually acquired only at rest. The influence of degree of 
stenosis on blood flow and metabolism during dobutamine 
infusion is usually not evaluated using this technique. 
Like others before them, Cban et al. (19) state that only 
recovery in function after revascularization denotes “clinically 
relevant” viability. Indeed, recovery in rest function after 
revasculariration may not be the only benefit of having nonisch- 
emit viable myocardium (21). Rest function improves after 
revascularization only when most of the endocardium is viable 
(14). The rest of the myocardium may be viable. but because it 
does not participate greatly in rest wall thickening (12,13). rest 
function will not improve after revasculariration if the endo- 
cardium is necrosed or tibrosed. However, the release of 
catecbolamines during stress could increase thickening in the 
viable myocardium in the outer layers of the !eft ventricular 
wall (45) and cortribute to enhanced global left ventricular 
systolic performance during that per&l. Thus, perhaps a better 
way to evaluate the success of revascularization is to assess left 
ventrictdar systolic function and size during stress rather than 
at rest. The presence of viabk myocardium in the outer 
myocardial layers may also contribute to maintaining left 
ventrkular w and size and to preventing infarct expansion 
and comequent heart failure and late mortal&y after acute 
myocardii infarction (10273). Thus, revascularization of 
dysrurtftional myocardium exhibiting evidence of ischemia 
JAW Vol. ?I. No. 7 
J”,W Iwxlfst!- I I 
makes eminent sense even if recovery in rest function is not 
seen after the procedure. 
Most diagnostic tests are interpreted on the basis of specific 
patterns. Although expedient, “pattern reading” leads to over- 
simplification in interpretation of test results. A case in point is 
the “hxed” thallium defect. Even when such a defect has consid- 
erable thallium uptake, it is often thought to rep:c%nt “scar.” In 
fact, thallium uptake in the myocardium several hours after 
injection. even when reduced. indicates the presence of viable 
cells. and patients with this pattern. demonstrate functional 
improvement after revascularization (25,29,30). As would be 
expected, positron emission tomography reveals intact metab- 
olism in many segments with fixed thallium defects and has 
thus become the reference standard for assessing viability in 
such patients (7,X). 
The same limitations of pattern reading are true for assess- 
ing viability using dobutamine echocardiography. In fact, even 
the expected i<?ponseb to dobutamine in the postischemic 
myocardium illurrrated in Figure I arc an oversimplification. 
Important confounding variables. such as the extent and 
magnitude of collateral blood Row. hdve been omitted for the 
sake of simplicity. Figure I merely attempts to provide a 
framework within which the results of dobutamine echocardi- 
ography can be interpreted. For correct interpretation, how- 
ever. a comprehensive understanding of coronary pathophysi- 
ology and knowledge of the specific clinical scenario are 
required. After all. as Goethe put it, “The eyes see what the 
mind knows.” 
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